肿瘤治疗电场作为头颈癌多模式治疗的新型联合伙伴
本研究在两种人头颈鳞癌细胞系中评估肿瘤治疗电场(TTFields)联合放疗和化疗的效果,发现放疗联合TTFields降低克隆存活的程度与放疗联合同步顺铂相当,三者联合进一步降低克隆存活,并增加细胞凋亡和DNA双链断裂,提示TTFields可能是局部晚期头颈鳞癌多模式治疗的有前景的联合伙伴。
要点
- 放疗联合TTFields降低克隆存活的程度与放疗联合同步顺铂相当。
- 放疗联合同步顺铂再加TTFields进一步降低克隆存活。
- TTFields联合放疗或放疗联合同步顺铂增加细胞凋亡和DNA双链断裂。
核心结论
- TTFields治疗似乎是局部晚期头颈鳞癌多模式治疗中有前景的联合伙伴。
- TTFields可用于强化放化疗或作为化疗的替代方案。
研究设计与样本
- 研究使用两种人头颈鳞癌细胞系(Cal27、FaDu),接受五种不同处理:TTFields、放疗加或不加TTFields、放疗联合同步顺铂加或不加TTFields。
- 采用克隆形成实验以及DAPI、caspase-3激活和γH2AX foci的流式细胞分析量化效果。
主要发现
- 放疗联合TTFields降低克隆存活的程度与放疗联合同步顺铂相当。
- 放疗联合同步顺铂再加TTFields进一步降低克隆存活。
- TTFields联合放疗或放疗联合同步顺铂增加细胞凋亡和DNA双链断裂。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We aimed to demonstrate the effects of tumor treating fields (TTFields) in head and neck squamous cell carcinoma (HNSCC) cells when combined with radiotherapy (RT) and chemotherapy. METHODS: Two human HNSCC cell lines (Cal27, FaDu) received five different treatments: TTFields, RT +/- TTFields and RT + simultaneous cisplatin +/- TTFields. Effects were quantified using clonogenic assays and flow cytometric analyses of DAPI, caspase-3 activation and γH2AX foci. RESULTS: Treatment with RT + TTFields decreased the clonogenic survival as strong as treatment with RT + simultaneous cisplatin. The triple combination of RT + simultaneous cisplatin + TTFields even further decreased the clonogenic survival. Accordingly, combination of TTFields with RT or RT + simultaneous cisplatin increased cellular apoptosis and DNA double-strand breaks. CONCLUSION: TTFields therapy seems a promising combination partner in the multimodal treatment of locally advanced HNSCC. It could be used to intensify chemoradiotherapy or as alternative to chemotherapy.
引用
- Regnery S, Franke H, Held T, et al. Tumor treating fields as novel combination partner in the multimodal treatment of head and neck cancer. Head Neck. 2023. PMID: 36872620. doi:10.1002/hed.27298
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。